Efbemalenograstim Alfa, an Fc Fusion Protein, Long‑Acting Granulocyte Colony-Stimulating Factor for Reducing the Risk of Chemotherapy-Induced Neutropenia: Results of a Phase II Randomized, Multicenter, Open‑Label Trial. [PDF]
Ji D +18 more
europepmc +1 more source
Is it a Drug or a Bug? A Case of Chemotherapy and Immune Modulators Complicating the Diagnosis of Ehrlichiosis [PDF]
Male, Heather J. +2 more
core +2 more sources
Successful Re-administration of Granulocyte Colony-Stimulating Factor Without Recurrence of Associated Vasculitis: A Case Report. [PDF]
Teshima K +5 more
europepmc +1 more source
Chemotherapy of advanced endometrial carcinoma [PDF]
Lilić Vekoslav +4 more
core +1 more source
The Influence of Blood Glucose Instability on Aortic Health in Diabetes: Evaluating the Role of G-CSF Therapy. [PDF]
Jafri I +9 more
europepmc +1 more source
Multidisciplinary Treatment for Cecal Cancer and Metachronous Liver Metastases in a Patient with Primary Autoimmune Neutropenia. [PDF]
Okawa K +3 more
europepmc +1 more source
Successful Treatment of Granulocyte Colony-Stimulating Factor-Related Aortitis in Prostate Cancer. [PDF]
Yamada S +8 more
europepmc +1 more source
Beyond Neutropenic Fever: Severe Multiorgan Immune-Related Toxicity Induced by Pembrolizumab. [PDF]
Anastácio M +4 more
europepmc +1 more source
Correction to: REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer. [PDF]
europepmc +1 more source

